Related by context. Frequent words. (Click for all words.) 57 Application BLA 55 www.delcath.com 55 Act PDUFA date 54 PRISTIQ 53 www.thallion.com 53 www.norsat.com 53 ATK undertakes 53 www.emergentbiosolutions.com 53 RR Donnelley disclaims 53 www.wellcare.com 53 Icatibant 53 theforward looking 52 renal toxicity 52 uncertainties materializes FICO 52 suchforward looking 52 Zelrix 52 Disclaimer Past performance 52 * Potentially libelous 52 http:/www.idg.com 52 GearUpForSports makes 51 www.bankofny.com 51 OsmoPrep 51 Combidex 51 Vilazodone 51 Humanitarian Device Exemption 51 http:/www.mcgraw-hill.com/ 51 www.hanabiosciences.com 51 anidulafungin 51 FDA approvable letter 51 By Thomas Gryta 50 Augment Bone Graft 50 Pharming website http:/www.pharming.com 50 Xinlay 50 Ixempra 50 FluLaval 50 ACS disclaims 50 Investigational Device Exemption 50 http:/www.fda.gov 50 application sNDA 50 Avastin bevacizumab 50 html entity decode 50 SAFE HARBOR Certain 49 Onsolis 49 companies visit www.osi 49 Drug Submission 49 Lexicon undertakes 49 ixabepilone 49 alogliptin 49 dalbavancin 49 Canvaxin 49 rhThrombin 49 #-#-PKI-NYSE 49 IIR quality 49 Silicon Image assumes 49 Exalgo 49 Cognizant undertakes 49 Updates advisories 49 Rhucin ® 49 Tessera assumes 49 Financing Condition 49 Standoutstocks.com profiles 48 OR SIMILAR STATEMENTS ARE 48 Junovan 48 risks anduncertainties 48 mysunshinecoast.com.au may 48 Nanobac Pharmaceuticals Inc. 48 European Medicines Evaluation 48 Furthermore Cephalon 48 www.tekmirapharm.com 48 forward.looking statements 48 within themeaning 48 Gestiva 48 Evicel 48 CHMP recommendation 48 ForexTV accepts 48 Afresa 48 craigdailypress.com does 48 Gilead assumes 48 FICO disclaims 48 contacting Kika Stayerman kika.stayerman 48 acquisitions mergers dispositions 48 Bioenvision compounds under 48 Mylotarg 48 symbol DIB 48 By Laurie Kulikowski 48 Oral Solution 48 -leukemias 48 NeutroSpec 48 IMVAMUNE R 48 VeriSign undertakes 48 TranSwitch indebtedness 47 feedback@financialwire.net 47 Amyvid 47 Calpine undertakes 47 #-#-# #ET Copyright c 47 Shamrockstocks 47 differmaterially 47 EARNINGS WATCH Updates advisories 47 Epithets abusive language 47 liprotamase 47 GSI Commerce expressly disclaims